Europe's drug regulator starts safety review of anemia drugs

04/28/2007 | MarketWatch

The European Medicines Agency says it is reviewing anemia drugs from Amgen, Roche Holding and Shire PLC to see if they increase the risk of heart and cancer problems. In the meantime, the agency recommended confining the drugs to their indicated use, for treating anemia. The agency says it also is cooperating on a review of Johnson & Johnson's Eprex, sold as Procrit in the U.S.

View Full Article in:

MarketWatch

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC